ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ALNY announcements Alnylam Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Alnylam Pharmaceuticals, Inc. Complete list of announcements declared & dividend announcements by Alnylam Pharmaceuticals, Inc. ALNY

Alnylam Pharmaceuticals, Inc. ALNY listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Alnylam Pharmaceuticals, Inc. ALNY

27 Analysts Assess Alnylam Pharmaceuticals: What You Need To Know
Analysts' ratings for Alnylam Pharmaceuticals (NASDAQ:ALNY) over the last quarter vary from bullish to bearish, as provided by 27 analysts. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 da
Announcement as on 31 March 2025

Raymond James Initiates Coverage of Alnylam Pharmaceuticals (ALNY) with Outperform Recommendation
Fintel reports that on September 29, 2023, Raymond James initiated coverage of Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Outperform recommendation.
Announcement as on 29 September 2023

: Alnylam Pharmaceuticals shares fall after FDA advisers weigh in on heart-disease drug
Alnylam Pharmaceuticals Inc. ALNY shares fell more than 8% premarket on Thursday after advisers to the U.S. Food and Drug Administration on Wednesday weighed the risks and benefits of the company’s treatment for a serious heart condition known as ATTR-CM
Announcement as on 14 September 2023

: Alnylam Pharmaceuticals’ stock to be halted Wednesday as FDA advisory panel reviews treatment for the Cardiomyopathy of ATTR Amyloidosis
Alnylam Pharmaceuticals Inc. ALNY said Wednesday its stock will be halted on Nasdaq through the day as a regulatory advisory committee will meet to review its new drug application for a treatment for the Cardiomyopathy of ATTR Amyloidosis. The treatment ca
Announcement as on 13 September 2023

Needham Reiterates Alnylam Pharmaceuticals (ALNY) Buy Recommendation
Fintel reports that on September 12, 2023, Needham reiterated coverage of Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy recommendation.
Announcement as on 12 September 2023

Announcements by Alnylam Pharmaceuticals, Inc. first page | Next page |

ALNY Alnylam Pharmaceuticals, Inc. current price & indicator signals

Moving Averages for Alnylam Pharmaceuticals, Inc.

  • 5Day Average: 461.87
  • 12Day Average: 451.98
  • 20Day Average: 450.85
  • 50Day Average: 457.09
  • 100Day Average: 439.33
  • 150Day Average: 392.59
  • 200Day Average: 356.03

ALNY Indicators & signals

Indicator MACD (12,26,9)

455.57, 454.14, -1.59
Indicator MACD is in positive zone

Indicator ADX (14)

20.33, 22.48, 14.89
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ALNY Alnylam Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
04 Thu Dec 2025 465.34 463.03 to 477.06 -1.68% 0.93 times
03 Wed Dec 2025 473.29 460.41 to 479.79 1.8% 1.03 times
02 Tue Dec 2025 464.93 453.01 to 472.48 2.28% 1.14 times
01 Mon Dec 2025 454.56 448.27 to 462.93 0.74% 1.01 times
28 Fri Nov 2025 451.23 444.43 to 455.76 1.37% 0.53 times
26 Wed Nov 2025 445.12 430.27 to 447.69 3.56% 0.86 times
25 Tue Nov 2025 429.80 428.57 to 441.82 -1.02% 0.95 times
24 Mon Nov 2025 434.23 420.30 to 444.67 -0.49% 1.65 times
21 Fri Nov 2025 436.38 433.50 to 449.53 -2.11% 1.23 times
20 Thu Nov 2025 445.79 445.34 to 467.73 -3.25% 0.74 times
19 Wed Nov 2025 460.76 456.90 to 465.32 -0.33% 0.84 times
18 Tue Nov 2025 462.30 456.27 to 469.11 0.38% 0.63 times

Videos related to: ALNY announcements Alnylam Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

ALNY announcements Alnylam Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

 

Back to top